Pharma

Dec 27 2017

Painkiller marketing secrets? Check Chicago – s unredacted suit against Endo, Purdue, Cephalon, et al #q #pharma

#chicago pharmaceutical companies # Painkiller marketing secrets? Check Chicago s unredacted suit against Endo, Purdue, Cephalon, et al. The city of Chicago made big news when it sued 5 drugmakers, alleging that their painkiller marketing broke the law. But much of the juicy detail in that lawsuit was hidden from view, redacted under a confidentiality agreement with the companies. Now, it’s open for viewing. As Bloomberg reports, a federal judge ruled that the information filed under seal could be made public, despite objections from two of the companies. The city then filed an amended complaint that’s mostly redaction-free. So, what …

Dec 7 2017

Endo Pharma to withdraw application for new opioid painkiller formulation #pharma #business

#endo pharma # Endo Pharma to withdraw application for new opioid painkiller formulation Endo Pharmaceuticals PLC has decided to withdraw its supplemental new drug application for the extended-release version of its Opana opiod painkiller but said it would continue to work with the U.S. Food and Drug Administration to advance the drug. Shares in the company ENDP, -2.03% added 2.4% to $23.55 in premarket trading. The pharmaceutical company, which is domiciled in Dublin and has U.S. headquarters in Malvern, Pa. plans to continue collecting and analyzing data on the drug and could refile. “We anticipate the generation of additional data, …

Dec 5 2017

Painkiller marketing secrets? Check Chicago – s unredacted suit against Endo, Purdue, Cephalon, et al #elite #pharma

#chicago pharmaceutical companies # Painkiller marketing secrets? Check Chicago s unredacted suit against Endo, Purdue, Cephalon, et al. The city of Chicago made big news when it sued 5 drugmakers, alleging that their painkiller marketing broke the law. But much of the juicy detail in that lawsuit was hidden from view, redacted under a confidentiality agreement with the companies. Now, it’s open for viewing. As Bloomberg reports, a federal judge ruled that the information filed under seal could be made public, despite objections from two of the companies. The city then filed an amended complaint that’s mostly redaction-free. So, what …

Nov 9 2017

Painkiller marketing secrets? Check Chicago – s unredacted suit against Endo, Purdue, Cephalon, et al #sk #pharma

#chicago pharmaceutical companies # Painkiller marketing secrets? Check Chicago s unredacted suit against Endo, Purdue, Cephalon, et al. The city of Chicago made big news when it sued 5 drugmakers, alleging that their painkiller marketing broke the law. But much of the juicy detail in that lawsuit was hidden from view, redacted under a confidentiality agreement with the companies. Now, it’s open for viewing. As Bloomberg reports, a federal judge ruled that the information filed under seal could be made public, despite objections from two of the companies. The city then filed an amended complaint that’s mostly redaction-free. So, what …

Oct 12 2017

Painkiller Addiction: Warning Signs You May Have Crossed the Line #warning #signs #of #alcohol #addiction, #painkiller #addiction #warning #signs

# Painkillers: 7 Warning Signs of Addiction By Kara Mayer Robinson WebMD archives content after 2 years to ensure our readers can easily find the most timely content. To find the most current information, please enter your topic of interest into our search box. “>From the WebMD Archives “Pain medication is. not really meant to be a way to maintain or manage chronic pain .” — Joe Schrank, MSW Many people worry that taking narcotic painkillers will lead to addiction. If your doctor prescribed medication to treat your pain and you take it as directed, you shouldn’t have a problem. …

Sep 30 2017

Endo Pharma to withdraw application for new opioid painkiller formulation #pharmaceutical #companies #jobs

#endo pharma # Endo Pharma to withdraw application for new opioid painkiller formulation Endo Pharmaceuticals PLC has decided to withdraw its supplemental new drug application for the extended-release version of its Opana opiod painkiller but said it would continue to work with the U.S. Food and Drug Administration to advance the drug. Shares in the company ENDP, -2.03% added 2.4% to $23.55 in premarket trading. The pharmaceutical company, which is domiciled in Dublin and has U.S. headquarters in Malvern, Pa. plans to continue collecting and analyzing data on the drug and could refile. “We anticipate the generation of additional data, …

Sep 5 2017

Endo Pharma to withdraw application for new opioid painkiller formulation #pharmaceutical #company #jobs

#endo pharma # Endo Pharma to withdraw application for new opioid painkiller formulation Endo Pharmaceuticals PLC has decided to withdraw its supplemental new drug application for the extended-release version of its Opana opiod painkiller but said it would continue to work with the U.S. Food and Drug Administration to advance the drug. Shares in the company ENDP, -2.03% added 2.4% to $23.55 in premarket trading. The pharmaceutical company, which is domiciled in Dublin and has U.S. headquarters in Malvern, Pa. plans to continue collecting and analyzing data on the drug and could refile. “We anticipate the generation of additional data, …

Aug 13 2017

Endo Pharma to withdraw application for new opioid painkiller formulation #the #pharmaceutical #industry

#endo pharma # Endo Pharma to withdraw application for new opioid painkiller formulation Endo Pharmaceuticals PLC has decided to withdraw its supplemental new drug application for the extended-release version of its Opana opiod painkiller but said it would continue to work with the U.S. Food and Drug Administration to advance the drug. Shares in the company ENDP, -2.03% added 2.4% to $23.55 in premarket trading. The pharmaceutical company, which is domiciled in Dublin and has U.S. headquarters in Malvern, Pa. plans to continue collecting and analyzing data on the drug and could refile. “We anticipate the generation of additional data, …

Jul 26 2017

UPDATED: Chicago makes second run at Allergan, J – J, Purdue and others with painkiller lawsuit #cardiome #pharma #corp

#chicago pharmaceutical companies # UPDATED: Chicago makes second run at Allergan, J J, Purdue and others with painkiller lawsuit Opioid makers thought they had dodged a litigation bullet 6 months ago when a federal judge dismissed a lawsuit by the City of Chicago trying to hold them accountable for an “epidemic” of painkiller, and even heroin, abuse. But the city is being tenacious and has refiled lawsuits claiming 6 drugmakers overstated the claims of the drugs’ benefits while downplaying their risks. The second amended complaint was filed on Thursday in Chicago against Purdue Pharma, Teva Pharmaceutical Industries ($TEVA), Johnson Johnson’s …

Jul 8 2017

Endo Pharma to withdraw application for new opioid painkiller formulation #top #biopharma #companies

#endo pharma # Endo Pharma to withdraw application for new opioid painkiller formulation Endo Pharmaceuticals PLC has decided to withdraw its supplemental new drug application for the extended-release version of its Opana opiod painkiller but said it would continue to work with the U.S. Food and Drug Administration to advance the drug. Shares in the company ENDP, -2.03% added 2.4% to $23.55 in premarket trading. The pharmaceutical company, which is domiciled in Dublin and has U.S. headquarters in Malvern, Pa. plans to continue collecting and analyzing data on the drug and could refile. “We anticipate the generation of additional data, …